The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dermocosmetics in management of cancer-related skin toxicities: International expert consensus.
 
Brigitte Dreno
Consulting or Advisory Role - Almirall; Bristol-Myers Squibb; Pierre Fabre; Roche/Genentech; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Kiarash Khosrotehrani
Honoraria - La Roche Posay
Consulting or Advisory Role - Novartis; Sanofi
Research Funding - Lilly O.
Patents, Royalties, Other Intellectual Property - Patent unrelated
Travel, Accommodations, Expenses - Novartis
 
Giselle De Barros Silva
Honoraria - BIO - Brazilian Information Oncology; Janssen; La Roche Posay; Merck
Consulting or Advisory Role - La Roche Posay
Speakers' Bureau - BIO - Brazilian Information Oncology; Janssen; La Roche Posay; Merck
Research Funding - La Roche Posay
(OPTIONAL) Uncompensated Relationships - Paxman
 
Julie Ryan-Wolf
Honoraria - UpToDate
Consulting or Advisory Role - VisualDx
Research Funding - Argentum Medical (Inst); Pfizer (Inst)
 
Delphine Kerob
Employment - La Roche-Posay
Stock and Other Ownership Interests - Stock options
Honoraria - La Roche-Posay
Research Funding - La Roche Posay
Travel, Accommodations, Expenses - La Roche Posay
 
Mark G. Trombetta
No Relationships to Disclose
 
Etienne Atenguena Okobalemba
Honoraria - La Roche Posay; Merck
Travel, Accommodations, Expenses - La Roche Posay; Merck
 
Pascale Dielenseger
Honoraria - AstraZeneca; GlaxoSmithKline; La Roche Posay; MSD Oncology; Mundipharma; Pfizer; SERVIER
Travel, Accommodations, Expenses - Pfizer
 
Meng Pan
No Relationships to Disclose
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Hoth Therapeutics; Incyte; Innovaderm; Janssen; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; L'Oreal; La Roche-Posay; Loxo; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Repare Therapeutics; Roche/Genentech; Seagen; Seattle Genetics/Astellas; Trifecta; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; Kinnate Biopharma; Kintara Therapeutics; Kintara Therapeutics; La Roche-Posay; Loxo; Loxo; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Repare Therapeutics; Repare Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris (Inst); Lutris (Inst); National Jewish Health (Inst); Novartis (Inst); novocure (Inst); novocure (Inst); OnQuality Pharmaceuticals; OnQuality Pharmaceuticals (Inst); Paxman (Inst)
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm